These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38564395)

  • 1. Clinical Impacts of Omalizumab on the Psychiatric Comorbidities of Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis.
    Tan MG; Bailey AMJ; Dorus B; Kirchhof MG
    J Drugs Dermatol; 2024 Apr; 23(4):e116-e117. PubMed ID: 38564395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stressful life events, psychiatric comorbidities and serum neuromediator levels in patients with chronic spontaneous urticaria treated with omalizumab.
    Elçin A; Ayla G; Tuba Saadet Deveci B; Özlem G; Murat Ö; Ahmet Selim B; Behçet C
    Allergol Immunopathol (Madr); 2024; 52(3):1-7. PubMed ID: 38721949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.
    Tagka A; Lambrou GI; Nicolaidou E; Nakou E; Makris M; Stratigos A; Katsarou A
    Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):39-50. PubMed ID: 32013838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.
    Vollono L; Piccolo A; Lanna C; Esposito M; Bavetta M; Campione E; Bianchi L; Diluvio L
    Drug Des Devel Ther; 2019; 13():3181-3186. PubMed ID: 31564834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.
    Johal KJ; Chichester KL; Oliver ET; Devine KC; Bieneman AP; Schroeder JT; MacGlashan DW; Saini SS
    J Allergy Clin Immunol; 2021 Jun; 147(6):2271-2280.e8. PubMed ID: 33713769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Strategy According to Differences in Response to Omalizumab in Patients With Chronic Spontaneous Urticaria.
    Giménez Arnau AM; Valero Santiago A; Bartra Tomás J; Jáuregui Presa I; Labrador Horrillo M; Miquel Miquel FJ; Ortiz de Frutos J; Sastre J; Silvestre Salvador JF; Ferrer Puga M
    J Investig Allergol Clin Immunol; 2019; 29(5):338-348. PubMed ID: 30222111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
    Liao SL; Yu M; Zhao ZT; Maurer M
    Front Immunol; 2021; 12():652973. PubMed ID: 33796115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab improves perceived stress, anxiety, and depression in chronic spontaneous urticaria.
    Patella V; Zunno R; Florio G; Palmieri M; Palmieri S; Brancaccio R
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1402-1404. PubMed ID: 33248284
    [No Abstract]   [Full Text] [Related]  

  • 9. Determinants of omalizumab drug survival in a long-term daily practice cohort of patients with chronic urticaria.
    Spekhorst LS; van den Reek JMPA; Knulst AC; Röckmann H
    Allergy; 2019 Jun; 74(6):1185-1187. PubMed ID: 30593687
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of omalizumab for treatment-refractory chronic spontaneous urticaria in a West Australian outpatient cohort.
    Farrah G; Stevenson B; Lie K; Brusch A
    Intern Med J; 2019 Apr; 49(4):526-528. PubMed ID: 30957371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory cytokine levels and changes during omalizumab treatment in chronic spontaneous urticaria.
    Hoşgören-Tekin S; Eyüboğlu İP; Akkiprik M; Giménez-Arnau AM; Salman A
    Arch Dermatol Res; 2024 May; 316(6):261. PubMed ID: 38795119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab retreatment in patients with chronic spontaneous urticaria: a systematic review of published evidence.
    Tonacci A; Nettis E; Asero R; Rossi O; Tontini C; Gangemi S
    Eur Ann Allergy Clin Immunol; 2020 May; 52(3):100-103. PubMed ID: 32108461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with Omalizumab for the treatment of chronic spontaneous urticaria in a tertiary center: real life experience.
    Acar A; Gerceker Turk B; Ertam Sagduyu I; Ceylan C; Ozturk G; Unal I
    Cutan Ocul Toxicol; 2020 Sep; 39(3):249-253. PubMed ID: 32597235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.
    Metz M; Vadasz Z; Kocatürk E; Giménez-Arnau AM
    Clin Rev Allergy Immunol; 2020 Aug; 59(1):38-45. PubMed ID: 32418171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study.
    Savic S; Leeman L; El-Shanawany T; Ellis R; Gach JE; Marinho S; Wahie S; Sargur R; Bewley AP; Nakonechna A; Randall R; Fragkas N; Somenzi O; Marsland A
    Clin Exp Dermatol; 2020 Dec; 45(8):1003-1010. PubMed ID: 32246853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.
    Skander D; Allenova A; Maurer M; Kolkhir P
    Eur Ann Allergy Clin Immunol; 2021 Mar; 53(2):91-93. PubMed ID: 32496030
    [No Abstract]   [Full Text] [Related]  

  • 17. Depression scores change significantly after omalizumab treatment in patients with chronic spontaneous urticaria.
    Can PK; Etikan P; Degirmentepe EN; Kocaturk E
    Asian Pac J Allergy Immunol; 2024 Jun; 42(2):132-137. PubMed ID: 33638627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis.
    Rubini NPM; Ensina LFC; Silva EMK; Sano F; Solé D
    Allergol Immunopathol (Madr); 2019; 47(6):515-522. PubMed ID: 31607407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.
    MacGlashan D; Saini S; Schroeder JT
    J Allergy Clin Immunol; 2021 Jun; 147(6):2295-2304.e12. PubMed ID: 33716077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab.
    Spertino J; Curto Barredo L; Rozas Muñoz E; Figueras Nart I; Gimenez Arnau A; Serra Baldrich E; Bonfill-Ortí M; Expósito-Serrano V; Guilabert A; Melé Ninot G; Villar Buil M; Garcias Ladaria J; García Navarro X; Vilavella M; Bielsa Marsol I; Aparicio Ortiz G; Baliu Piqué C; Álvarez Abella A; Lamas Domenech N; Mascaró JM; Gómez S; Torné Gutiérrez JI; Vicente Villa A; Gimenez Arnau A
    Actas Dermosifiliogr (Engl Ed); 2018 Nov; 109(9):771-776. PubMed ID: 30107875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.